Product Image

Glucosamine + Chondroitin + MSM

4.8
★ ★ ★ ★ ★
(756 ratings)
Potassium 180 mg
Product Image
Score81
A conventional joint blend with modest potassium chloride. Its mineral content is a side benefit, not a strong reason to use it for heart support.
How scoring works
Capsule
Quantity:180 Capsule(s) • (60 servings)
Goals:

Score 81

A conventional joint blend with modest potassium chloride. Its mineral content is a side benefit, not a strong reason to use it for heart support.
How scoring works
$18.59($0.30 per serving)
iHerb
$ 19.55
Vitacost
$ 18.59
Report prices

Analysis

Glucosamine and chondroitin make up most of the formula, supported by a smaller MSM amount. Those ingredients fit joint routines rather than the stated cardiovascular goal.

Potassium chloride is an effective electrolyte form, but its amount is modest relative to daily dietary intake. The label also does not separate source-compound weight from elemental yield.

The capsules may suit someone who wants a traditional multi-ingredient joint product with a small potassium contribution. Shoppers focused on potassium or heart support would get better alignment from a dedicated formula.

Who is it for
  • Adults seeking glucosamine and chondroitin
  • Users who prefer capsules over large tablets
  • People who view potassium as secondary
Best for
  • Multi-ingredient joint routines
  • Combining glucosamine, chondroitin, and MSM
  • Budget-conscious capsule use

Pros

  • Uses potassium chloride
  • Provides substantial glucosamine and chondroitin
  • Lists all main amounts separately

Cons

  • Potassium dose is modest
  • No broad cardiovascular ingredient coverage
  • Main ingredients serve joint rather than heart goals

Warnings

  • Chondroitin may increase bleeding risk with warfarin and other anticoagulant medicines.
  • People with kidney disease or taking potassium-sparing medicines should count the added potassium with other sources.
  • Glucosamine may cause nausea or other digestive discomfort in sensitive users.

Nutrient quality

86 Highest impact

Glucosamine and chondroitin provide substantial joint-support amounts with complementary MSM. The MSM contribution is modest, but the overall combination is focused and conservatively dosed.

Ingredient transparency

78 High impact

All active amounts are stated without a hidden blend. Complete directions, capsule excipients, and fuller source details for glucosamine and chondroitin are absent.

Customer satisfaction

71 High impact

The exceptional average rating and substantial review count make the aggregate satisfaction signal reasonably dependable. No detailed review text was provided, so recurring complaints and purpose alignment cannot be assessed.

Value for money

89 Highest impact

Substantial joint actives and a modest serving cost provide strong value. Focused composition makes the product competitive among combination joint formulas.

Report analysis

Ingredients

IngredientAmount per serving
Calories
10 Calorie(s)
Total Carbohydrates
2 Gram(s)
Potassium (Potassium Chloride)
180 mg
Glucosamine Sulfate
1.1 Gram(s)
Chondroitin Sulfate (Cartilage)
1.2 Gram(s)
Methylsulfonylmethane
300 mg
Adults 18–50
Report overview
D+ Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyB- Value

Potassium chloride supplies a useful electrolyte form but lacks the broader buffering role of preferred organic forms. The serving provides only a moderate amount, and the label does not separately state elemental yield. Its low serving cost partly offsets the limited potassium potency.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  2. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  3. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  4. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length.
    Behers BJ; Behers BM; Stephenson-Moe CA; Vargas IA; Meng Z; Thompson AJ; Melchor J; Wojtas CN; Rosario MA; Baker JF; Deevers AC; Mouratidis RW; Sweeney MJ · Nutrients · 2024
    Meta-analysisHeart Health forPotassium
  5. Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative.
    Seth A; Mossavar-Rahmani Y; Kamensky V; Silver B; Lakshminarayan K; Prentice R; Van Horn L; Wassertheil-Smoller S · Stroke · 2015
    Cohort study90,137 participantsHeart Health forPotassium
  6. Effect of high potassium diet on endothelial function.
    Blanch N; Clifton PM; Petersen KS; Willoughby SR; Keogh JB · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2015
    Randomized trial35 participantsHeart Health forPotassium
  7. Associations between sodium, potassium, and blood pressure: results from the Hispanic Community Health Study/Study of Latinos, a prospective cohort study.
    Swift SL; Sotres-Alvarez D; Raij L; Wassertheil-Smoller S; Schneiderman N; Llabre M; Zeki Al Hazzouri A; Rundek T; Van Horn L; Daviglus M; Castaneda S; Youngblood M; Mossavar-Rahmani Y; Elfassy T · The American journal of clinical nutrition · 2024
    Cohort study11,429 participantsHeart Health forPotassium
  8. Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables.
    Toledo CC; Vellosa Schwartzmann P; Miguel Silva L; da Silva Ferreira G; Bianchini Cardoso F; Citelli Ribeiro V; Paim LR; Antunes-Correa LM; Carvalho Sposito A; Matos Souza JR; Modolo R; Nadruz W; Fernandes de Carvalho LS; Coelho-Filho OR · ESC heart failure · 2021
    Cohort study178 participantsHeart Health forPotassium
  9. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
    Núñez J; Bayés-Genís A; Zannad F; Rossignol P; Núñez E; Bodí V; Miñana G; Santas E; Chorro FJ; Mollar A; Carratalá A; Navarro J; Górriz JL; Lupón J; Husser O; Metra M; Sanchis J · Circulation · 2019
    Cohort study2,164 participantsHeart Health forPotassium
  10. Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
    Vardeny O; Vaduganathan M; Claggett BL; Desai AS; Jhund PS; Lam CSP; Senni M; Shah SJ; Voors AA; Zannad F; Pitt B; Matsumoto S; Merkely B; Zieroth S; Yilmaz MB; Lay-Flurrie J; Viswanathan P; Horvat-Broecker A; Scalise A; McMurray JJV; Solomon SD · JAMA cardiology · 2025
    Randomized trial6,001 participantsHeart Health forPotassium